Clinical Researcher—October 2023 (Volume 37, Issue 5)
BY THE NUMBERS
Curated by Gary W. Cramer, Managing Editor for ACRP
$500 million The Biden Administration’s investment across 13 projects as the latest installment in the federal government’s Project NextGen, a $5 billion plan to develop new COVID-19 treatments, vaccines, and ways of delivering them. The Health and Human Services Department this summer channeled $1.4 billion to similar goals.
Source: https://www.statnews.com/2023/10/13/covid-vaccines-castlevax-codagenix-gritstone/
174% The increase in value of venture capital investments in the pharma/biotech sector from the second quarter of 2013 to the same period of 2023.
125 How many pharma, biopharma, and contract research organizations are being surveyed by CluePoints in partnership with the Tufts Center for the Study of Drug Development on current risk-based quality management practices.
21 The number of prioritized device guidance documents that the U.S. Food and Drug Administration’s Center for Devices and Radiological Health intends to publish in fiscal year 2024—three of them as final guidances and 18 as draft guidances.
5 The number of startup healthcare companies that will participate in the 2023 accelerator program run by HeartX, a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market.
▲▼▲
